Treatment Dilemmas in HIV Infection

Abstract
Recent trials of early treatment with the nucleoside analogues have produced conflicting data, raising fundamental questions about this therapy. Nevertheless, these drugs do lengthen clinical latency and delay the onset of AIDS, and for that reason alone should not be abandoned. The new treatment guidelines of the National Institute of Allergy and Infectious Diseases are discussed.